-
Intellia Therapeutics (NASDAQ:NTLA) Given "Neutral" Rating at JPMorgan Chase & Co.
来源: Buzz FX / 01 3月 2025 08:21:14 America/New_York
Intellia Therapeutics (NASDAQ:NTLA) Given "Neutral" Rating at JPMorgan Chase & Co. Written by MarketBeat March 1, 2025 Share Link copied to clipboard. Intellia Therapeutics ( NASDAQ:NTLA - Get Free Report ) 's stock had its "neutral" rating
Read more...